Related Experiment Video
Updated: Jan 24, 2026
Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
LINKS BETWEEN RENIN-ANGIOTENSIN SYSTEM GENETIC POLYMORPHISMS AND LEPTIN SECRETION IN OBESE HEART FAILURE PATIENTS
A Dadarlat1, D Pop1,2, L Procopciuc1
1"Iuliu Haţieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Insights
This review explores genetic links between the renin-angiotensin-aldosterone system (RAS) and leptin in obese heart failure patients. Understanding these connections may improve treatment for this growing patient population.
Area of Science:
- Cardiology
- Genetics
- Endocrinology
Background:
- Chronic heart failure (CHF) and obesity are prevalent, often co-occurring conditions.
- Obesity presents diagnostic and therapeutic challenges in CHF management.
- Genetic factors may influence susceptibility to heart failure independent of lifestyle.
Purpose of the Study:
- To explore links between renin-angiotensin-aldosterone system (RAS) genetic polymorphisms and leptin secretion in obese heart failure (HF) patients.
- To elucidate potential mechanisms underlying these relationships.
- To facilitate more precise HF treatment strategies for obese individuals.
Main Methods:
- Review of existing literature on RAS genetic polymorphisms.
- Analysis of studies investigating adipokine secretion, specifically leptin, in obese HF patients.
- Exploration of biological pathways connecting genetic variations and endocrine function.
Main Results:
- Adipose tissue acts as an endocrine organ secreting adipokines and RAS components, implicating it in CHF pathogenesis.
- Specific RAS genetic polymorphisms may influence leptin secretion.
- This interplay is crucial for understanding HF in obese populations.
Conclusions:
- Genetic variations in the RAS system are potentially linked to altered leptin secretion in obese heart failure patients.
- Further research into these genetic and endocrine interactions is warranted.
- Understanding these mechanisms can lead to personalized therapeutic approaches for obese HF patients.
Abstract:
Chronic heart failure (CHF) and obesity are two conditions frequently associated and which, despite all the advances made in their management in the recent years, their prevalence continues to rise. Obese patients present unique challenges in the diagnosis of CHF and also therapeutic particularities. The genetic differences may be a possible explanation for the fact that some people, irrespective of their lifestyle and common classical cardiovascular risk factors, are more susceptible to develop heart failure. Moreover, the adipose tissue, a huge endocrine organ which secretes adipokines, is also a well-established source of all renin-angiotensin-aldosterone system components, being strongly involved in the pathogenesis of CHF. That is why this review will explore the possible links between the RAS genetic polymorphisms and leptin secretion in obese HF patients, trying to bring a more precise understanding of this relationship, which will undoubtedly facilitate a more appropriate treatment of HF in obese patients. We also try to explain the possible incriminated mechanisms, and plausible biological explanations for the relationship between RAS genetic polymorphisms and adipokines secretion in obese heart failure patients.
More Related Videos
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:21Drug Dosing: Obese Patients
01:29Heart Failure II: Pathophysiology
01:17Pathophysiology of Heart Failure
01:27Heart Failure I: Introduction
01:22Heart Failure VI: Adjunct Therapies